CDTX - Cidara Therapeutics - Stock Price & Catalysts • BiopharmIQ

Enterprise Value

70.96M

Cash

47.98M

Avg Qtr Burn

-3.941M

Short % of Float

2.50%

Insider Ownership

9.46%

Institutional Own.

32.25%

Qtr Updated

03/31/23

Drug Pipeline

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & Indication	Stage & Event	Catalyst Date
Rezafungin Details Infectious disease, Fungal infections, Candidemia	Approved Quarterly sales	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
Rezafungin Details Infectious disease, Fungal infections	Phase 3 Data readout	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
CD388 (DFCs) Details Infectious disease, Influenza	Phase 2a Data readout	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.